V
VYNE Therapeutics D
D
VYNE
1.17000
USD
-0.01
(-0.85%)
مغلق
حجم التداول
18,777
الربح لكل سهم
-1
العائد الربحي
-
P/E
-1
حجم السوق
19,497,924
الأخبار المقالات
العنوان: VYNE Therapeutics
القطاع: Healthcare
الصناعة: Biotechnology
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.